Pfizer, Takeda and BB Biotech invested a combined $88m in the offering, conducted less than five months after Myovant spun out of Roivant Sciences.

Novo, Novartis and Amgen all recorded exits as blood disorder therapeutics developer Ra floated in the middle of its range.

The Novo, St. Jude and Kaiser Permanente-backed cardiac diagnostics technology developer floated above its range and closed its first day of trading 53% up on its IPO price.

Bayer invested $35m in the Switzerland-based gene editing company but it floated below its range and lowered the number of shares in the offering.

Shareholders in the semiconductor memory technology provider include Western Digital and GlobalFoundries, while GigaDevice Semiconductor is investing $5m.

The gastric balloon developer has gone public, after raising more than $70m in debt and equity from investors including Bader Sultan & Bros and AmorePacific.

The cloud enterprise platform, backed by Sapphire Ventures, is set to make its debut on Nasdaq today after securing nearly $238m in an initial public offering yesterday.

China-based data analysis software producer Gridsum Holding has floated in the US, giving exits to Nokia Growth Partners and Disney affiliate Steamboat Ventures.